RUSSIA - Anti-Coronavirus Drug for Export

Arno Froese

Russia may start exports of Avifavir, an anti-COVID-19 drug, after the domestic demand is satisfied, Chief Executive Officer of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev and First Deputy Minister of Industry and Trade Sergey Tsyb told an online conference.

“As Russia’s demand is satisfied, we suggest that exports may also be started. There are many requests from Middle Eastern countries, from Latin American countries. Russia may become an exporter of that drug,” Dmitriev said.

“In the future the drug has export potential as well, from the viewpoint of helping people in other countries that need high-tech products for tackling the coronavirus infection today,” Tsyb said, adding that there are several drugs to tackle particularly the coronavirus in the portfolio of Russian companies, which are undergoing the clinical trials stage.

Avifavir, produced by a joint venture of RDIF and ChemRar Group, is the first Russian Favipiravir-based drug, which has been used in Japan since 2014 against severe forms of influenza.

According to the results of ten days of clinical trials, Avifavir demonstrated safety with no new or previously unreported side effects detected. Efficacy of the drug is above 80%, a criterion for a drug with high antiviral activity. The start of the final stage of Avifavir clinical trials involving 330 patients was approved by the Russian Ministry of Health on May 21, 2020., 1 June 2020

Arno's Commentary

How effective Avifavir will be is yet to be seen. But Russia’s pharmaceutical industry is going full blast. At the time of writing (beginning of June), Russia’s deaths by coronavirus stand at 3.36 per 100,000 in population, which is significantly better than most European nations, who have been hit the hardest. That’s most unexpected, because Europe claims to be the richest, freest, and most prosperous continent on earth. 

As the coronavirus wanes a few months down the road, the picture may look somewhat different. 

What we do know is that the whole world has been affected; virtually the entire planet has shifted into emergency mode, awaiting some kind of silver bullet. But, even so, it will only be the end of one virus. There are many more to come.

Arno Froese is the executive director of Midnight Call Ministries and editor-in-chief of the acclaimed prophetic magazines Midnight Call and News From Israel. He has authored a number of well-received books, and has sponsored many prophecy conferences in the U.S., Canada, and Israel. His extensive travels have contributed to his keen insight into Bible prophecy, as he sees it from an international perspective.

Read more from this author

ContactAbout UsPrivacy and Safety